Health Archive » September, 2006

Health - September, 2006

133 articles

• C.R. Bard Agrees To Pay $20M To Settle Catheter Suit
• Report: FDA Should Improve Defibrillator Communication
• Baxter Gets Surprise Setback In Japanese Ultane Ruling
• Tenet Bandages Wounds With Corporate Integrity Deal
• Barr Launches Generic Actiq
• Lawsuit Over High-Tech Braces Settled With $20M Deal
• SeraCare Shareholders Denied Bid To Slow Proceedings
• Sanofi-Aventis Scores Trademark Victory
• King & Spalding Lures In IP Prosecution Team
• Jury Deadlocks In Wyeth Hormone Replacement Trial
• European Court Sides With Glaxo In Dual Pricing Case
• Merck Scores Second Win In Vioxx Onslaught
• HealthSouth Pays $445M To Settle Derivative Suit
• Health Coverage Dropping Among Small Companies
• Encysive Pharmaceuticals Hit With Securities Suit
• Federal Circuit Upholds Dietary Supplement Rulings
• Hospital Employee Pleads Guilty To Bid-Rigging
• Drug Makers Toss Authorized Generic Plan
• As Vioxx Deadline Looms, Merck Faces More Suits
• Novartis' Indian Patent Challenge Could Harm: MSF
• EU Regulator To Re-Examine Safety Of Common Drugs
• Hospital Stole Trade Secrets, Biotech Firm Charges
• Scrushy Moves For New Trial
• Hemophiliacs Sue Anthem For Breach Of Contract
• J&J Sues Abbott, Boston Scientific For Over $5.5B
• Study Finds FDA Falling Short of Drug Safety Expectations
• Genetic Discrimination Bill Introduced In Congress
• Schwarzenegger Kills Universal Health Care Bill
• Merck Lawyers Can Dig Through Juror's Personal Records
• FDA Plans Studies Of On-The-Market Medications
• New Jersey Hospitals Present Unique Outlier Cases
• Guidant Sues St. Jude Over Salespeople Recruitment
• Merck Appeals $26M Jury Verdict In First Vioxx Case
• Appeals Court Upholds Dismissal Of Enzo Fraud Claim
• Congress Pens Deal To Allow Canada Drug Imports
• Doctors Bring Class Action Against Health Insurers
• Male Enhancement Maker Charged With Fraud
• Cytyc Reaffirms Offer For Vision Systems
• Senate Battle Lies Ahead For FDA Nominee
• Connetics Hit With Shareholder Lawsuit Over Failed Drug
• Court To Reconsider Whistleblower Claims
• Federal Circuit Rules In Scantibodies' Favor
• Judge Rules For Sanofi, Bristol-Myers In Plavix Case
• Pediatrix To Pay $25M For Medicaid Overbilling
• HCA Denies Claims Of Anti-Competitive Behavior
• SeraCare Modifies Chapter 11 Plan Amid Rival Bids
• California Blue Cross Alters Rescission Policies
• GlaxoSmithKline Royalties Come Under Scrutiny
• Takeda Wins Attorneys Fees In Patent Suit
• AMS Health Sciences Settles Ephedra Suit
• Fueled By IP, U.S. Still Biotech Leader: Study
• Datasci Settles Patent Litigation Against Datalabs
• CareFirst Moves Fast To Address Policy Suit
• Challenge To Medicaid Law Has No Standing: Judge
• Forest Executives Win Battle Against Shareholders
• Antitrust Fears Raised Over Potential Rite Aid Merger
• Judge Orders ImClone's Scientists Off Patent
• Enzo Settles DNA Patent Dispute
• Appeals Court Vacates Securities Class Action Decision
• Pfizer Not Happy With Former Executive's Book
• UnitedHealth, HCA Square Off In Colorado Court
• Messy Health Care Merger To End Up In Court
• Wyeth Wins First Hormone Replacement Therapy Case
• In Win For Barr, Court Denies Tamoxifen Rehearing
• Powell Goldstein Nabs Chief AMA Lobbyist
• CalPERS Named Lead Plaintiff In UnitedHealth Suit
• FTC Clarifies Contact Lens Competition Rules
• Guidant Buries One Hatchet In Defibrillator Fallout
• Clotting Data Prompts FDA To Promise Stent Review
• Bristol-Myers Begs Court To Preserve Plavix Injunction
• Execs Sentenced For Marketing Unapproved Devices
• Australia Bids To Bolster Generic Drug Industry
• Concessions Mark Solvay Settlement
• Schwarzenegger Terminates California Wal-Mart Bill
• Isolagen Wins Dismissals Of Shareholder Suits
• Baker Donelson Nabs White House Bigwig
• Pulmonetic Punches VersaMed With Suit
• Biopure Escapes Damages In SEC Suit, GC Doesn't
• Acambis Says Willing To Settle In Patent Fight
• Mixed Victory For Pfizer In Dutch Lipitor Battle
• FDA Panel Shoots Down Oscient Request
• Battle Between Medical Device Makers Continues
• FDA Whistleblower Blasts New Merck Painkiller
• SeraCare Loses Control Of Its Chapter 11 Case
• Cross Country Healthcare Settles California Wage Suit
• Ex-HealthSouth CFO Resentenced
• Companies Battle Over Bone Cleaning Technology
• Court Revives Unfair Labor Case Against St. Vincent
• Judge Bounces Derivative Suit Against Cell Therapeutics
• Jury Mulls Evidence In Wyeth Premarin Trial
• Amgen's Preemptive Strike Survives Motion To Dismiss
• Stryker Plays Down DOJ Probe
• Bristol-Myers Head Fired Amid Plavix Debacle
• TriZetto Hands Over $15M To End Patent Litigation
• FDA Concerned With Side Effect of Oscient Drug
• SEC Hits Valeant With Multi-Pronged Probe
• FDA Advisors Question Mercury Fillings Report
• Jury Hands Innogenetics $7M In Damages
• Whistleblower Case v. Pfizer Dismissed
• DOJ Joins Whistleblower Suit Against Merck Affiliate
• Pharmacists' Suit Over Morning-After Pill To Proceed
• Nassau Health Care Corp. Hit With Racial Bias Suit
• Glaxo Agrees To $3.4B Settlement
• Barr Tries To Cut Generic Market By Entering It
• DEA Wants To Change Rules For Schedule II Drugs
• PTO Strikes Down Ariad's Patent
• The Deficit Reduction Act: Spotlight On Medicaid Enforcement
• Pfizer Faces New Personal-Injury Suits Over Lipitor
• Law Firm's Investigation Finds Merck Innocent
• Acambis Gets Boost With Smallpox Vaccine Ruling
• Apotex Appeals Plavix Injunction To Federal Circuit
• Howrey Adds Three Experts To Brussels Office
• Medical Method Patents
• Fulbright Raids Sonnenschein To Expand Health Care Group
• GlaxoSmithKline Scores Parallel Trade Victory
• Congress Eyes Antitrust Exemption For Insurers
• Novartis Sues To Protect Market For Epilepsy Drug
• California Governor Will Nix Health Care Bill
• Federal Circuit Hits J&J Unit With One-Two Punch
• J&J To Cough Up Millions More In Patent Case
• Biotech Companies Settle Animal Cloning Patent Suit
• Medtronic Settles With Gyrus In Financial Draw
• FDA Hits Snooze Button on Neurocrine's Sleep Drug
• Judge Denies Apotex Bid For Stay On Injunction
• Class Action Against Pharmaceutical Co. Dismissed
• Roche Wants New Ruling On Tarceva
• Biotech Companies Settle Secretive Patent Suit
• Abbott Defeated In HCV Patent Feud
• FDA Rejects Sanofi-Aventis Drug Application
• Pfizer Wins Another Battle In Norvasc War
• Compounded Medicines Legal, Federal Judge Rules
• Court Grants Injunction Barring Generic Plavix
• Judge Refuses To Review Amgen Case